ANI Pharmaceuticals(ANIP) - 2024 Q2 - Quarterly Results

Exhibit 99.1 FOR IMMEDIATE RELEASE ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance • Generated record quarterly net revenues of $138.0 million, representing year-over-year growth of 18.4%, and record Rare Disease net revenues of $49.2 million, an increase of 102.4% yearover-year • Delivered adjusted non-GAAP EBITDA of $33.2 million, and adjusted non-GAAP diluted earnings per share of $1.02 • Net loss available to common shareholders of $(2.7) million and diluted GA ...